These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16550516)

  • 1. A Chinese family with hemophilia B Leyden due to T-->A transition at position +6 of the FIX gene.
    Chan V; Ha SY; Au P; Lam C; Chan TK
    Am J Hematol; 2006 Apr; 81(4):300-1. PubMed ID: 16550516
    [No Abstract]   [Full Text] [Related]  

  • 2. First case report of hemophilia B Leyden in Japan.
    Yamashita A; Nagae C; Mori M; Ashikaga T; Kojima T; Taki M
    Int J Hematol; 2017 Jul; 106(1):135-137. PubMed ID: 28168417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
    Vidaud D; Tartary M; Costa JM; Bahnak BR; Gispert-Sanchez S; Fressinaud E; Gazengel C; Meyer D; Goossens M; Lavergne JM
    Hum Genet; 1993 Apr; 91(3):241-4. PubMed ID: 8478007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive increase in FIX level in males with haemophilia B Leyden and c.35G > A mutation in early childhood not related to androgen effect.
    Ahmed SZ; O'Rourke M; Jenkins V; Regan I; Nolan B
    Br J Haematol; 2020 Jun; 189(6):e262-e265. PubMed ID: 32346856
    [No Abstract]   [Full Text] [Related]  

  • 5. Haemophilia B Leyden arising de novo by point mutation in the putative factor IX promoter region.
    Royle G; Van de Water NS; Berry E; Ockelford PA; Browett PJ
    Br J Haematol; 1991 Feb; 77(2):191-4. PubMed ID: 2004020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype).
    Reitsma PH; Mandalaki T; Kasper CK; Bertina RM; Briët E
    Blood; 1989 Feb; 73(3):743-6. PubMed ID: 2917196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The putative factor IX gene promoter in hemophilia B Leyden.
    Reitsma PH; Bertina RM; Ploos van Amstel JK; Riemens A; Briët E
    Blood; 1988 Sep; 72(3):1074-6. PubMed ID: 3416069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The high frequency of the -6G-->A factor IX promoter mutation is the result both of a founder effect and recurrent mutation at a CpG dinucleotide.
    Morgan GE; Figueiredo MS; Winship PR; Baker R; Bolton-Maggs PH; Brownlee GG
    Br J Haematol; 1995 Mar; 89(3):672-4. PubMed ID: 7734378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-specific regulation of clotting factor IX gene expression in normal and transgenic mice.
    Boland EJ; Liu YC; Walter CA; Herbert DC; Weaker FJ; Odom MW; Jagadeeswaran P
    Blood; 1995 Sep; 86(6):2198-205. PubMed ID: 7662969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemophilia B Leyden: a sex-linked hereditary disorder that improves after puberty.
    Briët E; Bertina RM; van Tilburg NH; Veltkamp JJ
    N Engl J Med; 1982 Apr; 306(13):788-90. PubMed ID: 7062952
    [No Abstract]   [Full Text] [Related]  

  • 11. Another genetic variant of haemophilia B: haemophilia B Leyden.
    Veltkamp JJ; Meilof J; Remmelts HG; van der Vlerk D; Loeliger EA
    Scand J Haematol; 1970; 7(2):82-90. PubMed ID: 5450691
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of non-resolving hemophilia B Leyden in a 42-year-old male (F9 promoter + 13 A>G).
    James PD; Stakiw J; Leggo J; Walker I; Lillicrap D
    J Thromb Haemost; 2008 May; 6(5):885-6. PubMed ID: 18315547
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemophilia B Leyden].
    Briët E; van Leeuwen-Cornelisse IS; van der Vlerk D; van Tilburg NH
    Ned Tijdschr Geneeskd; 1986 Jul; 130(29):1324-7. PubMed ID: 3748213
    [No Abstract]   [Full Text] [Related]  

  • 14. A new case of severe hemophilia B Leyden, associated with a G to C mutation at position -6 of the factor IX promoter.
    Nguyen P; Cornillet P; Potron G
    Am J Hematol; 1995 Jul; 49(3):259-60. PubMed ID: 7604825
    [No Abstract]   [Full Text] [Related]  

  • 15. A mutation in the 3' untranslated region of the factor IX gene in four families with hemophilia B.
    Vielhaber E; Jacobson DP; Ketterling RP; Liu JZ; Sommer SS
    Hum Mol Genet; 1993 Aug; 2(8):1309-10. PubMed ID: 8401514
    [No Abstract]   [Full Text] [Related]  

  • 16. [The current feature of the study on human coagulation factor IX mutant].
    Yan JB
    Yi Chuan; 2005 Sep; 27(5):833-8. PubMed ID: 16257919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of age on factor IX levels in symptomatic carriers of Haemophila B Leyden.
    Hildyard C; Keeling D
    Br J Haematol; 2015 May; 169(3):448-9. PubMed ID: 25382638
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study on factor IX gene mutation in 74 hemophilia B patients].
    Liu J; Xiang H; Liu L
    Zhonghua Xue Ye Xue Za Zhi; 2001 Sep; 22(9):467-9. PubMed ID: 11758226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of a cohort of US patients with hemophilia B.
    Li T; Miller CH; Driggers J; Payne AB; Ellingsen D; Hooper WC
    Am J Hematol; 2014 Apr; 89(4):375-9. PubMed ID: 24375831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in bleeding phenotype in Amish carriers of haemophilia B with the 31008 C-->T mutation.
    Sharathkumar A; Hardesty B; Greist A; Salter J; Kerlin B; Heiman M; Sulkin M; Shapiro A
    Haemophilia; 2009 Jan; 15(1):91-100. PubMed ID: 18721150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.